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The Board of Registration in Pharmacy hereby submits The Annual Report of The 
Board for fiscal year ending June 30, 1978 in accordance with G.L. C.112, s.25. 
The Board, Its Function and Composition 
The Board of Registration in Pharmacy dates back to 1885, twenty-one years before 
President Theodore Roosevelt signed into law The Federal Food, Drug and Cosmetic 
Act. 
It represents one of the first consumer protective agencies established to elevate 
the standards of practice and to protect the consumer against acts of deceit, mal-
practice, substitution of drugs, the illegal use of counterfeit drugs and gross 
misconduct in the practice of the profession. 
The Board represents a State Administrative Agency with quasi-judicial authority 
which implements and maintains the organization, standards and procedures with 
respect to the professional conduct and practices of pharmacies, pharmacists and 
wholesale druggists for the protection of the health, safety and welfare of the 
citizens of the Commonwealth. 
In order to safeguard the interests of the general public, The Board individually 
and cooperatively with other state and federal agencies, monitors and enforces 
relevant federal and state statutory and regulatory provisions to insure quality 
standards of pharmacy education, training and practice. 
The Board has suspension and revocation powers authorized by law. After a hearing 
The Board may suspend or revoke a license or registration for cause. The Board 
may suspend the certificate of registration of a pharmacist if in its judgement, 
the person is a menace to the public by reason of improper use of intoxicating 
liquor or drugs. The Board may suspend or revoke a certificate, license or regis-
tration if it appears to The Board that the holder thereof is insane, guilty of 
deceit, malpractice, gross misconduct in the practice of the profession, or any 
offense against The Code of Professional Conduct or Pharmacy Laws. 
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Under provisions of the Massachusetts Controlled Substances Act, The Board may 
suspend a permit without a prior hearing and the registration of the pharmacy 
if in the opinion of The Board there is "imminent danger" to the public health and 
safety; provided however, that a prompt hearing is forthcoming. The suspension 
continues until the conclusion of the proceedings, including judicial review, or 
unless there is a court order by a court of competent jurisdiction. These type 
of cases usually deal with illegal distribution of controlled substances which 
have a high potential for abuse. Illegal sale of controlled substances, drug 
diversion are high in the priority list of The Board's functions in the area of 
enforcement. No one questions the fact that drug misuse and abuse are deleterious 
to society and an erosion of human dignity. 
We can agree that regulatory agencies should be responsive to the needs and prob-
lembs of the licensees, but should have as a primary concern, the regulation of 
these licensees to serve the interest and welfare of the public. Boards were not 
intended to become protective agencies serving professional members rather than 
the public, and The Board of Pharmacy is no exception. 
The Board's most important function is to respond effectively to the unlawful or 
unethical activity of the licensees as soon as possible after notification. The 
Board must be able to take immediate action against licensees who are proven 
offenders without relying upon the criminal courts where prosecution may be delay-
ed for years. 
The removal of the practitioner or professional from the environment which was 
responsible for his or hers unlawful act is essential to serve the interests of 
the public and to deter further drug diversion. 
Consumer complaints are received by direct communication with the consumer, 
through The Office of Consumer Affairs; The Massachusetts Consumers' Council; 
local consumer Councils; The office of Consumer Protection of Attorney General; 
local law enforcement agencies etc. In most cases, consumer complaints are 
based on price differentials. However, some serious complaints are derived from 
consumers, also such as errors in dispensing and drug diversion by illegal re-
filling of prescriptions or illegal distribution. 
The Board is composed of five members appointed by the Governor. Each serves a 
five year term. Each year one of the member's term expires on November 31 and 
he/she may be reappointed as of December 1 or replaced by a new member. Four 
of the Board members are registered pharmacists. Three of these pharmacists rep-
resent retail pharmacies. One of these pharmacists represents the hospital pharm-
acies and the fifth member is a public member representing the consumer. 
Presently the following constitute The Board membership: 
Saul E. Rosen of Brookline, President (retail pharmacist), 
Charles F. Monahan, Jr. of Worcester (retail pharmacist), 
Edward B. Nassif of North Adams, (retail pharmacist), 
Eleanor M. Pendergast of Middleton, (hospital pharmacist), 
John E. Stallworth of Osterville, (public member). 
The Executive Secretary is Dr. Romulus L. DeNicola, is under Civil Service and 
appointed by The Board. The statute provides for six agents to be assigned to 
The Board for routine inspections and investigations of licensees. However, 
the Board is only funded for four agents. The agents are appointed by the Board 
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and are also under Civil Service. 
registered pharmacist. 
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It is a requirement that an agent must be a 
The Board agents may inspect drugstores and other places of business wherein drugs, 
medicinals and medical supplies are sold or distributed. Among the duties of the 
agents are the following: routine inspections, monitoring of foreclosures, re-
ceiverships, bankruptcies, fire andfiood affecting the premises of licensees, 
conducting inventories and accountability of controlled substances of licensees, 
maintenance and enforcement of specific standards for all controlled substances 
by registrants, resolving consumer complaints, special investigations dealing with 
drug diversion, illegal dispensing, monitoring compliance with The Mass. Formulary 
Law etc. 
The present agents of The Board are as follows: 
Zauven R. Surabian of Arlington, 
Henry L. Berg of Holden, 
Louis R. Pacifico of Arlington, 
Joseph T. Labelle of Springfield. 
It is extremely difficult to cope with the increased activity by relying upon 
four agents. The Board is in dire need of the two additional agents authorized 
by law to carry on its duties and discharge its responsibilities. 
The clerical staff consists of two persons, a Principal Clerk - Kathleen A. 
Pemberton of West Roxbury who replaced Grace A. Mastropietro of Revere on 
September of 1977, and a Senior Clerk, Lena L. Gulla of Malden. Additional 
office help is wanting. The workload disposed of by these two clerks is 
phenomenal and they are to be complimented for their efforts and dedication. 
The staff is working with limited resources and adverse conditions. 
Charles F. Monahan, Jr. of Worcester was sworn in on May 10, 1978 as a retail 
pharmacy member. Mr. Monahan Jr., replaced Francis B. Finni of New Bedford, 
whose term expired and failed to be reappointed. The first meeting attended 
by the new member was on May 30, 1978. 
On July 12, 1977 a number of applicants were interviewed for a provisional 
appointment pending Civil Service Examination as Inspector for The Board, to 
fill a vacancy created by the resignation of Agent Edmund S. Fitzpatrick, 
(December 1, 1976) who has since deceased. Further interviews were conducted 
on July 26, 1977. On August 9, 1977, a final screening was made by summoni ng 
the top three contestants for a final interview • . T~ Board after a thorough 
review of the applicants appointed on a unanimous vote - Joseph T. LaBelle of 
Springfield. The appointment was made in accordance with the accepted mechanism 
employing The Affirmative Action process. 
On December 6, 1977, at its organizational meeting in accordance with Chapter 13, 
section 23 General Laws, the Board voted unanimously to elect Saul E. Rosen, 
President of The Board, succeeding the position held by Francis Finni. 
The Board is a member of The National Association of Boards of Pharmacy(NABP). 
NABP issues periodically a newsletter with important information for Board use. 
The pUblication relates to legal case decisions of the courts, rules and reg-
ulations and laws of other states, a roster of personnel of allied agencies etc. 
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The National Association of Boards of Pharmacy also makes available on a yearly 
basis licensure requirements for all reciprocal states, forty-seven in all. 
NABP is the vehicle for reciprocities between states. The National Association 
also provides for courses in Pharmacy Law and Law Enforcement at no expense to 
the agents or members of the Board. This is a very desirable experience. The 
courses are often given in conjunction with personnel of the federal agencies. 
The Association serves as a "pulse" for National Pharmaceutical standards. 
Regional meetings and National meetings are held periodically and the material 
and programs are a source of education. 
Education - Reciprocity - Examinations 
The Board has adopted The American Council on Pharmaceutical Education (ACPE) 
as the accrediting agency for undergraduate professional education. The ACPE 
is the only accrediting agency in pharmacy. It is an autonomous agency whose 
membership is derived through The American Association of Colleges of Pharmacy 
(AACP), The American Pharmaceutical Association (APhA), The National Association 
of Boards of Pharmacy (NABP) and The American Council in Pharmaceutical Education 
(ACPE). In addition, a panel consisting of public representatives, serves in 
an advisory capacity to the Council and provides for public contribution to its 
proceedings. The Council is recognized by the United states Commissioner of 
Education and Welfare and The Council on Post-secondary Accreditations. The 
Board utilizes The American Council on Education pUblication of a list of 
approved colleges each year. 
students in Pharmacy are required to complete a five year course of study in an 
accredited or approved college or school of pharmacy. The curricula embraces 
demanding courses of study in Chemistry, Physics, Biology, Mathematics, Pharmacy, 
Pharmacology, Business Administration and in The Humanities. The student must 
complete an internship program of a minimum of 1500 hours under a qualified pre-
ceptor approved by The Board. The internship program provides a balance between 
actual competence and the formal educational proficiency of the student. 
The Board adopts the NABP licensure examination (NABPLEX) to examine the candidates 
for licensure to practice pharmacy in the Commonwealth. The examination is devel-
oped "in cooperation with Educational Testing Service (ETS) of New Jersey. The 
facilities for conducting the examinations are provided by the Massachusetts 
College of Pharmacy at no cost to the Commonwealth. The proctors are supplied by 
The Board at no additional cost to the Commonwealth. 
In the early days the profession perpetuated itself by the apprenticeship system. 
There was no formal education involved. Practical experience and training was 
acquired under the tutorship of a pharmacist. Examinations are held twice a 
year. The examination is administered in a period of two days. The candidate 
is examined in the following subjects: Chemistry, Mathematics, Pharmacology, 
Practice of Pharmacy, Pharmacy and Pharmacy Drug Law. 
On August 2, 1977, The Board met for the compiling of marks as a result of the 
NAPBLEX Examination administered on June 30 and July 1, 1977. 294 candidates 
were examined. Students were from ten different colleges. There were 90 failures 
recorded - (30.6% of the total candidates). On January 25, 26, 1978, 139 can-
didates were examined for licensure. Markings were completed on March 23, 1978. 
41 candidates failed to pass the examination. (29.4%). 
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The Board during the fiscal year approved forty-three applications for reciprocity 
with nineteen states. The number of reciprocities is on the increase. There 
appears to be a national trend of pharmacists being mobile. It also appears that 
the younger pharmacists are the ones who are moving the most; fifty percent are 
thirty years old or under. The NABP reported 3,361 reciprocities during the 
year nation wide. 
The NABP committee on Foreign Pharmacy Graduates (FPG's) in association with the 
American Association of Colleges of Pharmacy (AACP) Committee on FPG's and the 
American Council on Pharmaceutical Education - is continuing a study relative to 
reciprocation of foreign graduates in Pharmacy. Graduates of foreign colleges do 
not qualify in most states including Massachusetts. There are a number of foreign 
graduates who reside in the Commonwealth but there is presently no mechanism for 
reciprocation. The committee on foreign students must undertake to develop and 
utilize a uniform system of evaluation which will permit the assessment of the 
educational qualifications of these foreign professionals. 
On November 15, 1977, President Finni and Board Members, Eleanor Pendergast, 
Saul Rosen, and Executive Secretary, Dr. Romulus DeNicola met at the Faculty Center 
of Northeastern University to enter a discussion on pharmaceutical education and 
its relationship to the results of the State Board Examinations. The Board was 
interested in the evaluation of the college curricula, a review of current interests 
and a look into the future needs and developments in pharmaceutical education. The 
University was represented by Acting Dean Warner, Professor Joseph Palumbo, Dr. 
Albert Taubman, Professor Delti and Ms. Karen Ramberg. 
A similar conference was held at the Massachusetts College of Pharmacy, Longwood 
Avenue, Boston, towards the end of the previous fiscal year. 
On June 29, 30, 1978, The Board conducted an examination for licensure of registered 
pharmacists. A total of 267 candidates representing eleven colleges took the 
examination. Results of this examination pending ETS notification, results of 
which will appear in the next fiscal year report. 
Rules, Regulations and Legislation 
Legislation enacted in 1976 establishing a Formulary Commission in order to prepare 
a list of "Interchangeable Drugs" and to authorize the Department of Public Health 
to promulgate pertinent regulations to implement the law is not in effect since the 
regulations and the list are not yet available. The Department of Public Health 
must devise an approved prescription form with a two line format. The line one 
bearing the prescriber's signature will mandate that the pharmacist dispense an 
interchangeable drug listed in the Formulary. The line two bearing the prescriper' s 
signature requires that the pharmacist dispense the prescription as written. The 
intent of the legislation is to lower the prescription costs to the consumer by 
encouraging the prescribing of interchangeable counterparts of certain brand-name 
products at a lesser expense. Presently, thirty-nine states have some form of 
generic or interchangeable drug statutes permitting product selection by the 
pharmacist. 
On october 19, 1977, the Governor approved H-1581 as Chapter 653 Acts and Resolves 
1977. an Act to further regulate the registration of drugstores. This law amended 
section 39 of Chapter 112, General Laws by adding a stipulation that the Board shall 
within one-hundred and fifty days after the filing of an application, render a final 
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decision denying or allowing registration. Failure to render such a decision, 
except when such failure to act is caused by the delay of the applicant, shall 
constitute an approval of the application and a permit shall be issued. This 
does not present any problem with the Board since the history of the Board does 
not show delays in expediting an application unless such delays were warranted 
by circumstances beyond the Board's control. 
On November 3, 1977, the Governor approved an Act providing that certain inter-
changeable drug violations be reported to The Board of Registration in Pharmacy 
and The Board of Registration and Discipline in Medicine. (Ch. 707 of The Acts 
of 1977). 
Prior to this Amendment to The Formulary Law, The Secretary of Consumer Affairs 
referred a consumer complaint of non-compliance with the law to the Office of 
The Attorney General. The present mechanism provides for the Secretary to refer 
the complaint to The Board of Registration in Pharmacy. 
The Board through The Division of Registration introduced three bills to the 
legislature namely: H-208, H-209, H-210. Unfortunately the bills were not 
passed by the legislature although in the opinion of The Board they represent 
desirable and uncontroversial bills. The Board intends to re-introduce these 
bills in the next legislative session. 
H-208 - pertained to the dispensing, possession and distribution of hypodermic 
needles and syringes. The purpose was to designate the "pharmacy" which is the 
registrant to possess and dispense these instruments. It also provided for the 
proper disposition of needles and syringes after the termination of use to correct 
a public hazard. The bill also provided for adequate record-keeping provisions. 
H-209 - the intent of this bill was to define certain terms not defined in C.94C 
(Mass. Controlled Substances Act) such as "Administrative Inspection Warrant", 
"Controlled Premises", and "Wholesale Druggist". The bill also would made the 
law consistent with the U.S. Supreme Court · Decision (U.S. vs Biswell, 406, U.S. 
311-May 1972) whereby the licensing agency with regulatory authority may make a 
routine inspection of the premises of its licensee with the procurement of an 
Administrative Inspection Warrant. The bill also details the do's and don't's 
of the inspecting agent. 
H-210 - Amends the present law in respect to conformance with federal regulations 
in the dispensing of drugs to dependent purposes and record keeping procedures. 
Present law refers to federal statutes but not the regUlations implementing the 
statute. Since the federal regulations go ' beyond the statute in respect to 
imposing requirements dealing with prescriptions, inventories and record-keeping 
provisions. In a recent Massachusetts case the Judge failed to take judicial 
notice of regUlations under The Comprehensive Drug Abuse and Control Act of 
1970 - (CFR-1306.07). The prescriber was charged with unlawful dispensing of 
a controlled substance by means of prescribing for a dependent person (C.94C, s.19). 
On October 18, 1977 The Federal Food and Drug Administration (FDA) regulations on 
patient package inserts (PPI) for estrogens went into effect. Under this order all 
prescription drugs containing estrogens must be accompanied by a patient package 
insert. These are supplied by the manufacturer through the suppliers. Non-
compliance is tantamount to misbranding and the dispensing pharmacist will be 
subject to criminal prosecution. positive factors supporting the use of PPI's 
are as follows: 
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the consumer is alerted to possible side effects of the prescribed drug. Serious 
side effects can be reported. The patient could also be advised of side effects 
which are not of a serious nature. The consumer may with a better understanding 
of the drug and dosage, and method of administration, be in a better position to 
prevent non-compliance with the therapy. The importance of continuing the medi-
cation in cases even though the symptons of illness are no longer apparent is 
stressed, (ex. antibiotics). The PPI's can serve to educate the patient in the 
proper use of the drug and eliminating the chance of over-utilization or under-
utilizing which may spell disaster in either case. The PPI's may also encourage 
a better dialogue between the prescriber and the pharmacist in rendering explain-
ation of terms, etc. The negative effects of the use of PPI's may be that the 
patient may become alarmed and encouraged to self-medication. The PPI's if not 
clearly written may be misunderstood. In the near future, it is anticipated that 
the PPI's will be made available for a number of drugs which are considered 
important to deal with. 
On November 29, 1977, subsequent to rule making procedures pursuant to G.L. c. 30A, 
The Board held a public hearing on proposed new regulations. The statutory 
authority for the promulgation of these regulations follows: G.L. c. 30A, s. 2, 
G.L. c. 112, s. 42A, G.L. c. 112, s. 30, and G.L. c. 94C, s. 6. 
On March 28, 1978, The Board approved a finalized form of the regulations and on 
March 31, 1978 the regulations were submitted to The Office of The Secretary of 
State for adoption. 
The regUlations were published on April 6, 1978 which is the effective date of the 
regulations. These new regUlations repealed the former regulations, however do 
not effect the regulations promulgated jointly by The Board and The Department of 
Public Health, pursuant to G.L. c. 94C, relative to excluded non-narcotic compounds 
and excepted compounds under the Mass. Controlled Substances Act. 
In clear and concise language, the regUlations represent what the Board considers 
consistent with changes that have taken place in the standards of practice of 
the profession. Regulations on citizenship requirements and the prohibition of 
advertising of prescription drugs which have been deemed unconstitutional by 
the U. S. Supreme Court Decisions were repealed. Some important additions were 
made to The Code of Professional Conduct. The Board addressed to the area of 
dispensing information and advice that may be given to the consumer by the pharm-
acist. This action was acclaimed and editionalized nationally in recognized 
professional literature. It was also well received by consumer groups. Regulations 
governing the advertising of prescription drugs are consistent with The Federal Reg-
ulations under FDA and based on recent court decisions. The consumer is protected 
against misleading advertising, false claims and deception. The new regUlations 
also provide for a mechanism for the transferring of prescriptions via a copy, 
or other means from pharmacy to pharmacy to prevent accessability of the drug 
beyond the prescribed quantity. The regulations also provide for automated data 
processing systems for accountability purposes in accordance with provisions set 
forth in Title XXI, C.F.R. The Board also included regulations directed at the 
Prohibition and Compliance with the Equal Employment and Fair Business Practices 
Provisions of Mass. G.L., c. 1518. 
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statistical Information and Trends 
According to The Lilly Digest Calendar year 1977, community pharmacies showed a 
favorable increase in sales, however, the cost of goods sold rose at a fastcr 
rate and thereby the gross margin shrunk. Expenses stabilized at 31.5% of sales 
but net profit dropped to an all time low of 3 . 4%. 
According to National Prescription Audit (IMS America Ltd.) the total number of 
prescriptions in 1977 are 1.404 Billion (3.3% decline over 1976). The decline 
in prescriptions include both new and refills. Generically written prescriptions 
have gained one percentage point to 12.4% of the market. 
As of September 1978 there were 7404 registered pharmacists on record in Mass-
achusetts. 5,632 of the registered pharmacists resided in Massachusetts and 
1772 were out of state. This reduced the availability of a pharmacist to work 
in the Commonwealth to less than 4,000. The majority of the registered pharm-
acists are employed in retail pharmacy. Women entering the profession are 
steadily on the increase. During the fiscal year, 433 candidates were examined 
for licensure and the record shows that 18.2% were women. 
On September 30, 1977, a survey of Massachusetts pharmacies showed that fifteen 
chains are represented in the Commonwealth representing 11.72% of all pharmacies. 
Statistics show that there were 91 drugstore closures during the fiscal year 
ending June 30, 1978. Of these closures 88 were independent pharmacies and 
3 chain operated pharmacies. This dramatically indicates the decline of the 
sole proprietorship and an increase in the corporate type ownership, reflective 
of the chain pharmacy activity. Sixty-two new drugstore applications were 
processed. Of these, twenty were for independent stores and forty-two were 
chain operated stores. 
New pharmacy regulations have reduced the m1n1mum store hours from 80 to 72 hours 
per week in which a pharmacy should remain open to satisfy the needs of the 
community; however, there is a waiver provision within the regulation for less 
than 70 hours for cause. The decline in store hours in the Commonwealth is 
consistent with a national trend. This is probably due to the increase in payrol l 
and utility costs as well as the crime climate of today. 
In November of 1977 on the "Today Show" (NBC), Dr. Arthur Ulene spoke about 
pharmacists as the best source of drug information. Dr. Ulene was aware that 
pharmacists are, in fact, the repository of drug knowledge. 
Clinical Pharmacy has become a integral part of the pharmacy curricula. This 
phase of pharmacy brings the pharmacist in contact with the patient with emphasis 
on patient care on drug therapy. The purpose is to create a patient oriented 
attitude. The pharmacist develops skills in inter-professional and patient 
communication. 
Drug information centers are already a reality in our colleges of Pharmacy. 
Information is available on identification of foreign and domestic drugs, accepted 
dosage and availability, possible adverse effects, drug metabolism, drug to drug 
and food drug interactions, the use of drug in presence of disease conditions, 
etc. 
In Washington D.C., Capitol Hill 1S looking into the future to overhaul the drug 
laws. This major project may be in process for the next year or two. The main 
object of the proposed reform is to advance further consumer protection. Inform-
ation to the consumer must be improved; cost savings are to be promoted; unethical 
and misleading advertising is to be deleted; speed up of drugs to market; some 
drug de-regulation to encourage drug innovation; etc. 
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Board Activity and Miscellaneous 
Inter-state and intra-state communications and correspondence continues to plague 
the office staff with additional workload beyond the daily routine performances. 
Activity within the licensee transactions is on the increase. For example, there 
have been within the fiscal year, one-hundred twenty-five changes of Manager 
transactions, sixty-four changes of ownership, twenty-two drugstore removals, 
ninety-one closures and sixty-two new drugstore applications. These transactions 
require close scrutiny and are time consuming due to the complexity and nature 
of the pharmacy business. There have been over one-hundred breaking and entries 
of pharmacies and approximately sixty armed robberies of pharmacies. The 
inventories and methods of diversion are monitored by the office. A memorandum 
was issued to pharmacists to alert them of the problem and issued guidelines 
in the hope of detering the diversion. As a result of repeated hold-ups, 
vandalism, etc., several Massachusetts pharmacies have been forced to close their 
doors and discontinue their business after many years of service to the community. 
The office must monitor and maintain records of the internship program. If 
continued education is added in the near future, it will require a supervisor 
of the internship program and the continued education program. Presently, CE 
has come to the allied profession of Medicine, Dentistry and Nursing, so it is 
imminent that Pharmacy will be next. 
The CVS Pharmacy chain contemplated opening optical departments in certain 
designated stores operated by the chain. The Board met with Attorneys Paul 
Levenson and David Goldberg of the CVS Pharmacy chain, a dispensing optician 
and Allen stoll of The Optical Services Department of the chain. The optical 
department would be for the sole purpose of grinding and fitting lenses. The 
optician would be in the employ of the pharmacy for the purpose of delivering 
optical services which would be consistent with the fact that the pharmacy be 
separate and independent of any other business, in accordance with G.L. c. 112, 
s. 39. It was made clear to the Board that in case of conflict between the 
registered pharmacist manager and the employed optician that the pharmacy man-
ager would be the one in control. The Board undertook a review of all the 
rules and regulations and laws governing the practice of the optician and its 
relationship with other professions. The Board gathered all possible inform-
ation from fifteen states which permit such a practice to determine guidelines 
or establish policy and possible regulatory procedures. Based on the in-
depth study of this matter, the Board has approved plans for several of the 
chain store locations to install units for the sole purpose of the dispensing 
and grinding of lenses. 
On November 1, 1977, at the meeting of The Board, John Stallworth, public member 
gave a summation as to what had transpired at a caucus of Public Members of the 
Boards of Registration summoned by Christine Sullivan, Secretary of Consumer 
Affairs. The members were alerted to the fact that competitive price advertising 
of prescription drugs should be encouraged to a just degree. Consumer complaints 
should be handled swiftly and fairly. Decisions of The Board resulting in sus-
pensions or revocations should be publicized. There was a discussion on con-
solidation, including the reorganization of Board structures to allow additional 
public representation. Wherever possible, it was suggested that Board meetings 
be held in diverse parts of the State in order to give the Boards greater ex-
posure and an opportunity to retrieve information on views, problems, etc., of 
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the areas from the professionals and the consumers. The possibility of insurance 
for members of the Boards was discussed in case of lawsuit and on the question of 
immunity. 
On March 14, 1978, The Board met with representatives of The Massachusetts Rate 
Setting Commission to discuss proposed reimbursement methodology and the possi-
bility of the Board requiring pharmacies to keep on-going records of all new and 
refill prescriptions dispensed. The Commission was represented by Attorneys 
Timothy Taylor and Joseph Duffy. The pro-rating of reimbursement fee possibility 
was considered by basing the rate on the prescription volume (new and refills) 
of a pharmacy. The Commission was seeking an equitable mechanism for arriving 
at such a dispensing fee. The Board pointed out that the present law requires 
accurate record-keeping and filing systems for prescriptions. Studies of ratios 
between new prescriptions and refills are continuously available through market-
ing survey firms of repute. The Board is of the opinion that additional regula-
tions are not necessary to harness the required information requested by the 
Commission. In addition, The Board does not have an adequate number of invest-
igators to monitor the pharmacies as to the accuracy in reporting to the 
Commission. 
The Board was informed of the operation of the Drew Clinic of Roxbury operated 
by the Massachusetts College of Pharmacy Corporation. Since there may have 
been legal implications for operating a pharmacy under a clinic license, the 
Board called upon representatives of the college to a conference with the Board 
to review the matter. A date for the meeting is forthcoming. 
The Board on a continuous basis issues memoranda to transmit important and pert-
inent information to the profession. 
Example: Status of sales on hypodermic needles and syringes, changes in The 
Official Compendia, the notice of scheduling and re-scheduling of drugs under 
the State and Federal Controlled Substances Act, U.S. FDA Regulations and Drug 
Laws, revocation of requirements for Over-The-Counter Vitamin A - D - products, 
resume of licensure requirements for foreign pharmacists, etc. 
Students of the colleges of Pharmacy are addressed by the Board on subjects of 
licensing procedures, reciprocity, internship programs and the importance of 
proficiency and competence in the practice of the profession and their obliga-
tion to the public safety and welfare. 
The Executive Secretary, Romulus L. DeNicola and President, Francis B. Finni of 
The Board attended the Annual Meeting of The National Association of Boards of 
Pharmacy in New Orleans. 
The Board was represented at The New England Enforcement Officers Association 
Spring Conference on June 19 - 20, 1978 at the Sheraton Regal Inn in Hyannis 
Massachusetts. 
On June 8, 1978, a meeting \'las held between the Drug Enforcement Adminis·tration 
and the Massachusetts Professional organizations. The special meeting was 
held at the Drug Enforcement Administration - Boston Regional Office, Government 
Center. The program was sponsored by the Regional Director, Edward Cass of the 
Drug Enforcement Administration. Officials from Washington, D. C., took part 
in the program. The intent was to promote a good liaison between the profes-
sionals and D.E.A. in a committment to foster effective self-regulation and 
11 
voluntary compliance. Objectives of the conference was to discuss and rcview 
problems of concerned professionals exchange of information, promote a better 
relationship among the registrants, accords for self-regulation and current 
drug diversion problems. The Board was represented by its Executive Secretary. 
Between August 7 and August 18, 1978, The Drug Enforcement Administration 
sponsored a Drug Investigators Course at Holyoke, Massachusetts. At one 
of the sessions, the Board's Executive Secretary was a member of a panel 
along with Attorney Lynn Beck of The Board of Registration in Medicine and 
Discipline and a member of The Drug Investigative unit in a discussion and 
question and answer period. The course was directed at State Police and 
local police officers predominantly from Western Massachusetts. 
The Executive Secretary addressed the House of Delegates of the Massachusetts 
State Pharmaceutical Association in Springfield on "Pharmacy Law Update". 
The Executive Secretary was a featured speaker at a joint conference of 
The Dental Society, The Medical Society and the Massachusetts State 
Pharmaceutical Association on November 1977, at the Boston Harvard Club. 
The topic was "New Prescription Writing Legislation and Common Problems". 
Members of The Board have been called upon to appear before various 
religious and civic groups as speakers concerning The Board, its functions, 
consumerism, etc. 
The following pages relative to financial status, record of Board meetings 
and number of hearings held, decisions of the Board are self explanatory. 
BOARD OF REGISTRATION IN PHARMACY 
FINANCIAL STATEMENT 
FISCAL YEAR 1978 
JULY 1, 1977 thru JUNE 30, 1978 
INCOME 
Drug store Permits ......................................... $ 
Certi ficates of Fitness ••••••••••••••••••••• 
Whdeffile Druggists Licenses ••••••••••••••••• 
Drugstore Controlled substances ••••••••••••••••••••••.••••• 
Wholesale Controlled . Substances ••••••••••••••.•.••.•••••••• 
Hospital Controlled Substances ••••••••••••••••••••••••••••• 
Examination Fees .........................................•. 
Reinstatement Fees ........................................ . 
Reciproci ty Fees .......................................... . 
Duplicate Certificates .................................... . 
Certified statements •• ..................................... 
TOTAL NET RECEIPTS 
EXPENSES 
$ 
Executive Secretary, Services •••••••.•.•••••••••••••••••••• $ 
Agents Services ........................................... . 
Members Services .•...............•......•.................. 
Repairs ................................................... . 
Repairs, Accounts Payable ................................. . 
Travel - Members & Agents .•.•..••......•.•.....•..•.••..... 
Travel, Accounts Payable .................................. . 
Office Exp. from App. of Director of Registration •••••••••• 
Office Expense, Accounts Payable •••.••••••••••••••••••••••• 
Office Personnel Services ................................. . 
TOTAL EXPENSES $ 
57,715.00 
25,375.00 
6,000.00 
38,175.00 
1,500.00 
4,275.00 
10,775.00 
1,095.00 
2,800.00 
65.00 
262.00 
148,037.00 
21,266.05 
60,523.21 
5,250.00 
648.49 
551.50 
6,999.80 
1,799.82 
7,695.67 
2,216.51 
18,132.63 
125,083.68 
BOARD OF REGISTRATION IN PHARMACY 
JULY 1, 1977 to JUNE 30, 1977 
MEETINGS AND HEARINGS 
The number of Meetings of the Board (including Hearings) were ••••.•..•• 159 
These Meetings and Hearings included the following Categories: 
Applications for New Drugstores 
Applications for Wholesale Druggists 
Applications for Reciprocity and Duplicate Certificates 
Violations of the Code of Professional Conduct 
Violations of Chapter 112, Section 61 - (Gross Misconduct & Malpractice in the 
Practice of the Profession) 
Reinstatements of Licenses 
Rules & Regulations 
Non-Conformity with Federal Laws 
Proposed Changes on Rules & Regulations 
Rules & Regulations 
Examinations and Assembly of Markings, etc. 
RESULTS OF HEARINGS 
Drugstore Permits Revoked............................................... 2 
Personal Certificate of Registration Revoked •.•••••••••••••••••.••••••.. 1 
Personal Certificate of Registration Suspended •••.••••..•••••••••••••••• 8 
Drugstore put on Probation.............................................. 1 
Pharmacists put on Probation ............................................ 5 
Reciprocations Denied................................................... 2 
Drugstore Applications Denied •....................•..........••......... 1 
Wholesale Druggists License Denied ••••••••••••••••.••••••••.•••••.•••••• 1 
Reinstatement of Personal certificate Suspended ••••••••••.•••••.•.••.••• 1 
GENERAL INFORMATION 
Number of Drug stores .............................................. , .. 
Number of certificate of Fitness ••••.••••••••••••••••••.••••••••••••• 
Number of Controlled Substance (Retail} •••••••••••••••••••••••••••••• 
Number of controlled Substance (Hospital Pharmacies} •••••••••.••••••• 
Number of Controlled Substance (Wholesale} •••••.••••••••.••••••.••••• 
Change of Managers .................................................. . 
Change of Corporation &: OWTlers ...................................... . 
New Drug stores ..................................................... . 
C lased Drug stores .................................................. . 
Closed Hospital Pharmacies .......................................... . 
Drug stores Removed ................................................. . 
Acti ve Registered Pharmacists ....................................... . 
Active Registered Assistant Pharmacists ••••.••••••••••..•.•••••••.••• 
No. of Pharmacists who have Reciprocated with Other States ••••••••••• 
1389 
878 
1389 
195 
62 
125 
64 
62 
91 
5 
22 
7476 
47 
92 
BOARD OF REGISTRATION IN PHARMACY 
J ULY 1, 1977 to JUNE 30, 1978 
EXAMINATION FOR REGISTRATION AS PHARMACISTS 
Examined 
January 25, 1978 •.••..••.• 
June 30, 1978 •••••..• 
Total 
.139 
.269 
408 
Registered 
98 
211 
309 
REGISTERED BY MASSACHUSETTS THROUGH INTERSTATE RECIPROCITY 
Connecticut. · .............................. . 3 
Deleware. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
Illinois. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
Iowa •....•. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Kentucky •••••• · ............................... . 
Maine •••• 
Maryland •• 
Michigan .• 
Minnesota. 
· ................................. . 
· ................................. . 
..................................... 
..................................... 
Nevada .•..•.•. · ............................... . 
New Hampshire •• ................................ 
New york •••••• · ............................... . 
Pennsyl vania .................... . 
Rhode Island .................................. . 
Tennessee •• . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Virginia •••••••••• ............................. 
Washington ••• 
Washington D. C • 
............................. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
1 
1 
3 
2 
1 
2 
1 
1 
13 
2 
5 
1 
1 
2 
1 
West Virginia.................................. 1 
TOTAL. • • • • • • • • • • • • • • • • • • • 43 
r , 
'-
---- ...... ~ 
BY ORDER OF THE BOARD: 
q:;d7J1.~ ~ 
Romulus L. DeNicola, Pharm. D. 
Executive Secretary 
....., .t _ 
